Normalization of Sweat Chloride Concentration and Clinical Improvement With Ivacaftor in a Patient With Cystic Fibrosis With Mutation S549N

類似資料

• In Vivo and In Vitro Ivacaftor Response in Cystic Fibrosis Patients With Residual CFTR Function: N-of-1 Studies
  著者:: McGarry, Meghan E., 等
  出版事項: (2017)
• Protracted neonatal hypertrypsinogenaemia, normal sweat chloride, and cystic fibrosis
  著者:: Castellani, C, 等
  出版事項: (2000)
• Medical genetics: advances in brief: A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations
  著者:: Ravine, David
  出版事項: (1995)
• Cystic fibrosis mutations in heterozygous newborns with hypertrypsinemia and low sweat chloride.
  著者:: Castellani, C, 等
  出版事項: (1999)
• Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis
  著者:: Collaco, Joseph M., 等
  出版事項: (2016)